Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

China flag China · Delayed Price · Currency is CNY
59.99
+1.24 (2.11%)
May 30, 2025, 3:04 PM CST
-20.82%
Market Cap 47.14B
Revenue (ttm) 4.64B
Net Income (ttm) 1.84B
Shares Out 785.72M
EPS (ttm) 2.34
PE Ratio 25.62
Forward PE 22.62
Dividend 1.30 (2.17%)
Ex-Dividend Date May 28, 2025
Volume 7,063,355
Average Volume 4,210,351
Open 58.66
Previous Close 58.75
Day's Range 58.66 - 60.96
52-Week Range 49.01 - 97.20
Beta -0.45
RSI 67.25
Earnings Date Aug 22, 2025

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1995
Employees 2,841
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300832
Full Company Profile

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.